HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes

Generating neurons from human stem cells has potential for brain damage therapy and neurogenesis modeling, but current efficacy is limited by culture heterogeneity and the lack of markers. We have previously reported the heparan sulfate proteoglycans (HSPGs) glypican‐1 (GPC1) and ‐4 (GPC4) as the ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroscience research 2020-08, Vol.98 (8), p.1619-1645
Hauptverfasser: Oikari, Lotta E., Yu, Chieh, Okolicsanyi, Rachel K., Avgan, Nesli, Peall, Ian W., Griffiths, Lyn R., Haupt, Larisa M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1645
container_issue 8
container_start_page 1619
container_title Journal of neuroscience research
container_volume 98
creator Oikari, Lotta E.
Yu, Chieh
Okolicsanyi, Rachel K.
Avgan, Nesli
Peall, Ian W.
Griffiths, Lyn R.
Haupt, Larisa M.
description Generating neurons from human stem cells has potential for brain damage therapy and neurogenesis modeling, but current efficacy is limited by culture heterogeneity and the lack of markers. We have previously reported the heparan sulfate proteoglycans (HSPGs) glypican‐1 (GPC1) and ‐4 (GPC4) as the markers of lineage‐specific human neural stem cells (hNSCs) and mediators of hNSC lineage potential. Here, we further examined phenotypical characteristics and GPC1 and GPC4 during neural differentiation of hNSCs in the presence of two neurogenic growth factors reported to bind to heparan sulfate: brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). In hNSC neural cultures, GPC1 and GPC4 were expressed along neurites and cell bodies in long‐term (40–60 days) neural differentiation cultures demonstrating the areas of differential localization—suggesting potentially different functions. Neural differentiation cultures in the presence of BDNF or PDGF‐B generated phenotypically different neural cells with BDNF treatment associated with higher GPC4 versus GPC1 expression, increased heterogeneity, and differential neuron subtype marker expression to PDGF‐B cultures. PDGF‐B cultures exhibited higher levels of spontaneous activity and reduced heterogeneity over long‐term culture associated with decreased GPC4. Untreated neural cultures were highly variable, supporting the use of neuroregulatory growth factors for guided differentiation. Targeted siRNA downregulation of GPC1/4 reduced neural differentiation markers and altered response to exogenous BDNF and PDGF‐B. This work confirms GPC1 and GPC4 as regulators of human neural differentiation and supports their use as novel markers of neural cell characterization. Glypican‐1 (GPC1) and ‐4 (GPC4) have previously been reported as markers of lineage‐specific neural stem cells. Here, their pheonotypical characteristics were further examined under neuronal differentiation conditions in the presence of brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). GPC1 and GPC4 demonstrated differential localized expression during long‐term (40–60 days) neuronal differentiation, suggesting different functions within neural cells. Under BDNF conditions, higher GPC4 to GPC1 gene expression ratio correlated with increased heterogeneity, increased proliferation, and increased GABAergic marker expression. In contrast, PDGF conditions resulted in higher GPC1 to GPC4 gene expr
doi_str_mv 10.1002/jnr.24666
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2415299765</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2415299765</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3306-9f477c0b727a49f27bbd6d723d75df3cf5880f130aeebde00df49fc020c1b25a3</originalsourceid><addsrcrecordid>eNp10M1KAzEQB_AgCtbqwTcIeNHDtpNkN-kepWirFBU_zks2O7Fbttma7CK9-Qg-o0_itvUggqeB4TfDzJ-QUwYDBsCHC-cHPJZS7pEeg1RFcRKrfdIDISGKgfFDchTCAgDSNBE9spw-PUwCfa3Wq9Jo9_Xxyah2xe9GTLVHOm-X2lGHra-drujK1w2WLlAz116bBn0ZmtLQ2tKitBY9umarN3aOrm7WKwzH5MDqKuDJT-2Tl-ur5_E0mt1PbsaXs8gIATJKbayUgVxxpePUcpXnhSwUF4VKCiuMTUYjsEyARswLBChsxwxwMCzniRZ9cr7b25351mJosmUZDFaVdli3IeMxS3iaKpl09OwPXdSt717cKjmSIyF5py52yvg6BI82W_lyqf06Y5Btgs-64LNt8J0d7ux7WeH6f5jd3j3uJr4BP1KHyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2416868362</pqid></control><display><type>article</type><title>HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes</title><source>Access via Wiley Online Library</source><creator>Oikari, Lotta E. ; Yu, Chieh ; Okolicsanyi, Rachel K. ; Avgan, Nesli ; Peall, Ian W. ; Griffiths, Lyn R. ; Haupt, Larisa M.</creator><creatorcontrib>Oikari, Lotta E. ; Yu, Chieh ; Okolicsanyi, Rachel K. ; Avgan, Nesli ; Peall, Ian W. ; Griffiths, Lyn R. ; Haupt, Larisa M.</creatorcontrib><description>Generating neurons from human stem cells has potential for brain damage therapy and neurogenesis modeling, but current efficacy is limited by culture heterogeneity and the lack of markers. We have previously reported the heparan sulfate proteoglycans (HSPGs) glypican‐1 (GPC1) and ‐4 (GPC4) as the markers of lineage‐specific human neural stem cells (hNSCs) and mediators of hNSC lineage potential. Here, we further examined phenotypical characteristics and GPC1 and GPC4 during neural differentiation of hNSCs in the presence of two neurogenic growth factors reported to bind to heparan sulfate: brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). In hNSC neural cultures, GPC1 and GPC4 were expressed along neurites and cell bodies in long‐term (40–60 days) neural differentiation cultures demonstrating the areas of differential localization—suggesting potentially different functions. Neural differentiation cultures in the presence of BDNF or PDGF‐B generated phenotypically different neural cells with BDNF treatment associated with higher GPC4 versus GPC1 expression, increased heterogeneity, and differential neuron subtype marker expression to PDGF‐B cultures. PDGF‐B cultures exhibited higher levels of spontaneous activity and reduced heterogeneity over long‐term culture associated with decreased GPC4. Untreated neural cultures were highly variable, supporting the use of neuroregulatory growth factors for guided differentiation. Targeted siRNA downregulation of GPC1/4 reduced neural differentiation markers and altered response to exogenous BDNF and PDGF‐B. This work confirms GPC1 and GPC4 as regulators of human neural differentiation and supports their use as novel markers of neural cell characterization. Glypican‐1 (GPC1) and ‐4 (GPC4) have previously been reported as markers of lineage‐specific neural stem cells. Here, their pheonotypical characteristics were further examined under neuronal differentiation conditions in the presence of brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). GPC1 and GPC4 demonstrated differential localized expression during long‐term (40–60 days) neuronal differentiation, suggesting different functions within neural cells. Under BDNF conditions, higher GPC4 to GPC1 gene expression ratio correlated with increased heterogeneity, increased proliferation, and increased GABAergic marker expression. In contrast, PDGF conditions resulted in higher GPC1 to GPC4 gene expression ratio and resulting in decreased heterogeneity, increased spontaneous activity, and increased dopaminergic marker expression. Our results confirm GPC1 and GPC4 as human neural proteins providing a potential set of novel markers to characterize different neural cell populations in terms of maturity, heterogeneity, and subtype differentiation.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.24666</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Axons ; BDNF ; Biomarkers ; Brain damage ; Brain injury ; Brain-derived neurotrophic factor ; Cell culture ; Culture ; Differentiation ; Growth factors ; Heparan sulfate ; Heparan sulfate proteoglycans ; Heterogeneity ; Localization ; Neural stem cells ; Neurogenesis ; PDGF‐B ; Phenotypes ; Platelet-derived growth factor ; Proteoglycans ; Regulators ; RRID:AB_10671920 ; RRID:AB_2099233 ; RRID:AB_2286686 ; RRID:AB_2286949 ; RRID:AB_2340852 ; RRID:AB_2801499 ; RRID:AB_2827641 ; RRID:AB_306716 ; RRID:AB_330924 ; RRID:AB_443209 ; RRID:AB_444319 ; RRID:AB_446723 ; RRID:AB_561053 ; RRID:AB_631776 ; RRID:AB_776175 ; RRID:AB_92588 ; RRID:AB_92643 ; siRNA ; Stem cells ; Sulfates</subject><ispartof>Journal of neuroscience research, 2020-08, Vol.98 (8), p.1619-1645</ispartof><rights>2020 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3306-9f477c0b727a49f27bbd6d723d75df3cf5880f130aeebde00df49fc020c1b25a3</citedby><cites>FETCH-LOGICAL-c3306-9f477c0b727a49f27bbd6d723d75df3cf5880f130aeebde00df49fc020c1b25a3</cites><orcidid>0000-0002-7735-8110 ; 0000-0002-2299-8399</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjnr.24666$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjnr.24666$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Oikari, Lotta E.</creatorcontrib><creatorcontrib>Yu, Chieh</creatorcontrib><creatorcontrib>Okolicsanyi, Rachel K.</creatorcontrib><creatorcontrib>Avgan, Nesli</creatorcontrib><creatorcontrib>Peall, Ian W.</creatorcontrib><creatorcontrib>Griffiths, Lyn R.</creatorcontrib><creatorcontrib>Haupt, Larisa M.</creatorcontrib><title>HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes</title><title>Journal of neuroscience research</title><description>Generating neurons from human stem cells has potential for brain damage therapy and neurogenesis modeling, but current efficacy is limited by culture heterogeneity and the lack of markers. We have previously reported the heparan sulfate proteoglycans (HSPGs) glypican‐1 (GPC1) and ‐4 (GPC4) as the markers of lineage‐specific human neural stem cells (hNSCs) and mediators of hNSC lineage potential. Here, we further examined phenotypical characteristics and GPC1 and GPC4 during neural differentiation of hNSCs in the presence of two neurogenic growth factors reported to bind to heparan sulfate: brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). In hNSC neural cultures, GPC1 and GPC4 were expressed along neurites and cell bodies in long‐term (40–60 days) neural differentiation cultures demonstrating the areas of differential localization—suggesting potentially different functions. Neural differentiation cultures in the presence of BDNF or PDGF‐B generated phenotypically different neural cells with BDNF treatment associated with higher GPC4 versus GPC1 expression, increased heterogeneity, and differential neuron subtype marker expression to PDGF‐B cultures. PDGF‐B cultures exhibited higher levels of spontaneous activity and reduced heterogeneity over long‐term culture associated with decreased GPC4. Untreated neural cultures were highly variable, supporting the use of neuroregulatory growth factors for guided differentiation. Targeted siRNA downregulation of GPC1/4 reduced neural differentiation markers and altered response to exogenous BDNF and PDGF‐B. This work confirms GPC1 and GPC4 as regulators of human neural differentiation and supports their use as novel markers of neural cell characterization. Glypican‐1 (GPC1) and ‐4 (GPC4) have previously been reported as markers of lineage‐specific neural stem cells. Here, their pheonotypical characteristics were further examined under neuronal differentiation conditions in the presence of brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). GPC1 and GPC4 demonstrated differential localized expression during long‐term (40–60 days) neuronal differentiation, suggesting different functions within neural cells. Under BDNF conditions, higher GPC4 to GPC1 gene expression ratio correlated with increased heterogeneity, increased proliferation, and increased GABAergic marker expression. In contrast, PDGF conditions resulted in higher GPC1 to GPC4 gene expression ratio and resulting in decreased heterogeneity, increased spontaneous activity, and increased dopaminergic marker expression. Our results confirm GPC1 and GPC4 as human neural proteins providing a potential set of novel markers to characterize different neural cell populations in terms of maturity, heterogeneity, and subtype differentiation.</description><subject>Axons</subject><subject>BDNF</subject><subject>Biomarkers</subject><subject>Brain damage</subject><subject>Brain injury</subject><subject>Brain-derived neurotrophic factor</subject><subject>Cell culture</subject><subject>Culture</subject><subject>Differentiation</subject><subject>Growth factors</subject><subject>Heparan sulfate</subject><subject>Heparan sulfate proteoglycans</subject><subject>Heterogeneity</subject><subject>Localization</subject><subject>Neural stem cells</subject><subject>Neurogenesis</subject><subject>PDGF‐B</subject><subject>Phenotypes</subject><subject>Platelet-derived growth factor</subject><subject>Proteoglycans</subject><subject>Regulators</subject><subject>RRID:AB_10671920</subject><subject>RRID:AB_2099233</subject><subject>RRID:AB_2286686</subject><subject>RRID:AB_2286949</subject><subject>RRID:AB_2340852</subject><subject>RRID:AB_2801499</subject><subject>RRID:AB_2827641</subject><subject>RRID:AB_306716</subject><subject>RRID:AB_330924</subject><subject>RRID:AB_443209</subject><subject>RRID:AB_444319</subject><subject>RRID:AB_446723</subject><subject>RRID:AB_561053</subject><subject>RRID:AB_631776</subject><subject>RRID:AB_776175</subject><subject>RRID:AB_92588</subject><subject>RRID:AB_92643</subject><subject>siRNA</subject><subject>Stem cells</subject><subject>Sulfates</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp10M1KAzEQB_AgCtbqwTcIeNHDtpNkN-kepWirFBU_zks2O7Fbttma7CK9-Qg-o0_itvUggqeB4TfDzJ-QUwYDBsCHC-cHPJZS7pEeg1RFcRKrfdIDISGKgfFDchTCAgDSNBE9spw-PUwCfa3Wq9Jo9_Xxyah2xe9GTLVHOm-X2lGHra-drujK1w2WLlAz116bBn0ZmtLQ2tKitBY9umarN3aOrm7WKwzH5MDqKuDJT-2Tl-ur5_E0mt1PbsaXs8gIATJKbayUgVxxpePUcpXnhSwUF4VKCiuMTUYjsEyARswLBChsxwxwMCzniRZ9cr7b25351mJosmUZDFaVdli3IeMxS3iaKpl09OwPXdSt717cKjmSIyF5py52yvg6BI82W_lyqf06Y5Btgs-64LNt8J0d7ux7WeH6f5jd3j3uJr4BP1KHyQ</recordid><startdate>202008</startdate><enddate>202008</enddate><creator>Oikari, Lotta E.</creator><creator>Yu, Chieh</creator><creator>Okolicsanyi, Rachel K.</creator><creator>Avgan, Nesli</creator><creator>Peall, Ian W.</creator><creator>Griffiths, Lyn R.</creator><creator>Haupt, Larisa M.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7735-8110</orcidid><orcidid>https://orcid.org/0000-0002-2299-8399</orcidid></search><sort><creationdate>202008</creationdate><title>HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes</title><author>Oikari, Lotta E. ; Yu, Chieh ; Okolicsanyi, Rachel K. ; Avgan, Nesli ; Peall, Ian W. ; Griffiths, Lyn R. ; Haupt, Larisa M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3306-9f477c0b727a49f27bbd6d723d75df3cf5880f130aeebde00df49fc020c1b25a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Axons</topic><topic>BDNF</topic><topic>Biomarkers</topic><topic>Brain damage</topic><topic>Brain injury</topic><topic>Brain-derived neurotrophic factor</topic><topic>Cell culture</topic><topic>Culture</topic><topic>Differentiation</topic><topic>Growth factors</topic><topic>Heparan sulfate</topic><topic>Heparan sulfate proteoglycans</topic><topic>Heterogeneity</topic><topic>Localization</topic><topic>Neural stem cells</topic><topic>Neurogenesis</topic><topic>PDGF‐B</topic><topic>Phenotypes</topic><topic>Platelet-derived growth factor</topic><topic>Proteoglycans</topic><topic>Regulators</topic><topic>RRID:AB_10671920</topic><topic>RRID:AB_2099233</topic><topic>RRID:AB_2286686</topic><topic>RRID:AB_2286949</topic><topic>RRID:AB_2340852</topic><topic>RRID:AB_2801499</topic><topic>RRID:AB_2827641</topic><topic>RRID:AB_306716</topic><topic>RRID:AB_330924</topic><topic>RRID:AB_443209</topic><topic>RRID:AB_444319</topic><topic>RRID:AB_446723</topic><topic>RRID:AB_561053</topic><topic>RRID:AB_631776</topic><topic>RRID:AB_776175</topic><topic>RRID:AB_92588</topic><topic>RRID:AB_92643</topic><topic>siRNA</topic><topic>Stem cells</topic><topic>Sulfates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oikari, Lotta E.</creatorcontrib><creatorcontrib>Yu, Chieh</creatorcontrib><creatorcontrib>Okolicsanyi, Rachel K.</creatorcontrib><creatorcontrib>Avgan, Nesli</creatorcontrib><creatorcontrib>Peall, Ian W.</creatorcontrib><creatorcontrib>Griffiths, Lyn R.</creatorcontrib><creatorcontrib>Haupt, Larisa M.</creatorcontrib><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oikari, Lotta E.</au><au>Yu, Chieh</au><au>Okolicsanyi, Rachel K.</au><au>Avgan, Nesli</au><au>Peall, Ian W.</au><au>Griffiths, Lyn R.</au><au>Haupt, Larisa M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes</atitle><jtitle>Journal of neuroscience research</jtitle><date>2020-08</date><risdate>2020</risdate><volume>98</volume><issue>8</issue><spage>1619</spage><epage>1645</epage><pages>1619-1645</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Generating neurons from human stem cells has potential for brain damage therapy and neurogenesis modeling, but current efficacy is limited by culture heterogeneity and the lack of markers. We have previously reported the heparan sulfate proteoglycans (HSPGs) glypican‐1 (GPC1) and ‐4 (GPC4) as the markers of lineage‐specific human neural stem cells (hNSCs) and mediators of hNSC lineage potential. Here, we further examined phenotypical characteristics and GPC1 and GPC4 during neural differentiation of hNSCs in the presence of two neurogenic growth factors reported to bind to heparan sulfate: brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). In hNSC neural cultures, GPC1 and GPC4 were expressed along neurites and cell bodies in long‐term (40–60 days) neural differentiation cultures demonstrating the areas of differential localization—suggesting potentially different functions. Neural differentiation cultures in the presence of BDNF or PDGF‐B generated phenotypically different neural cells with BDNF treatment associated with higher GPC4 versus GPC1 expression, increased heterogeneity, and differential neuron subtype marker expression to PDGF‐B cultures. PDGF‐B cultures exhibited higher levels of spontaneous activity and reduced heterogeneity over long‐term culture associated with decreased GPC4. Untreated neural cultures were highly variable, supporting the use of neuroregulatory growth factors for guided differentiation. Targeted siRNA downregulation of GPC1/4 reduced neural differentiation markers and altered response to exogenous BDNF and PDGF‐B. This work confirms GPC1 and GPC4 as regulators of human neural differentiation and supports their use as novel markers of neural cell characterization. Glypican‐1 (GPC1) and ‐4 (GPC4) have previously been reported as markers of lineage‐specific neural stem cells. Here, their pheonotypical characteristics were further examined under neuronal differentiation conditions in the presence of brain‐derived neurotrophic factor (BDNF) and platelet‐derived growth factor‐B (PDGF‐B). GPC1 and GPC4 demonstrated differential localized expression during long‐term (40–60 days) neuronal differentiation, suggesting different functions within neural cells. Under BDNF conditions, higher GPC4 to GPC1 gene expression ratio correlated with increased heterogeneity, increased proliferation, and increased GABAergic marker expression. In contrast, PDGF conditions resulted in higher GPC1 to GPC4 gene expression ratio and resulting in decreased heterogeneity, increased spontaneous activity, and increased dopaminergic marker expression. Our results confirm GPC1 and GPC4 as human neural proteins providing a potential set of novel markers to characterize different neural cell populations in terms of maturity, heterogeneity, and subtype differentiation.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/jnr.24666</doi><tpages>27</tpages><orcidid>https://orcid.org/0000-0002-7735-8110</orcidid><orcidid>https://orcid.org/0000-0002-2299-8399</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0360-4012
ispartof Journal of neuroscience research, 2020-08, Vol.98 (8), p.1619-1645
issn 0360-4012
1097-4547
language eng
recordid cdi_proquest_miscellaneous_2415299765
source Access via Wiley Online Library
subjects Axons
BDNF
Biomarkers
Brain damage
Brain injury
Brain-derived neurotrophic factor
Cell culture
Culture
Differentiation
Growth factors
Heparan sulfate
Heparan sulfate proteoglycans
Heterogeneity
Localization
Neural stem cells
Neurogenesis
PDGF‐B
Phenotypes
Platelet-derived growth factor
Proteoglycans
Regulators
RRID:AB_10671920
RRID:AB_2099233
RRID:AB_2286686
RRID:AB_2286949
RRID:AB_2340852
RRID:AB_2801499
RRID:AB_2827641
RRID:AB_306716
RRID:AB_330924
RRID:AB_443209
RRID:AB_444319
RRID:AB_446723
RRID:AB_561053
RRID:AB_631776
RRID:AB_776175
RRID:AB_92588
RRID:AB_92643
siRNA
Stem cells
Sulfates
title HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T19%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HSPGs%20glypican%E2%80%901%20and%20glypican%E2%80%904%20are%20human%20neuronal%20proteins%20characteristic%20of%20different%20neural%20phenotypes&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Oikari,%20Lotta%20E.&rft.date=2020-08&rft.volume=98&rft.issue=8&rft.spage=1619&rft.epage=1645&rft.pages=1619-1645&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.24666&rft_dat=%3Cproquest_cross%3E2415299765%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2416868362&rft_id=info:pmid/&rfr_iscdi=true